← Eichor
Study identifier: NCT05773885 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Telerehabilitation in People With Parkinson's Disease

Condition: Parkinson's Disease  ·  Sponsor: IRCCS San Raffaele Roma

PhaseNA
Planned participants40
Who can joinAll sexes, 30 Years to 80 Years
Healthy volunteersNo

About this study

Although TeleRehabilitation (TR) is widely accepted as an appropriate model for the provision of professional health services in the field of physiotherapy, with already established standards, guidelines and policies, there are still few studies in the literature on the use of TR as a rehabilitation tool in people with Parkinson's Disease (PD). Therefore, further studies on the efficacy of TR in the management of motor and non-motor symptoms of PD are needed. The study TEMPO aims at assessing the efficacy (in terms of autonomy in carrying out the activities of daily life) of a home TR program based on serious games in people with PD compared to conventional day-hospital treatment.

This description comes directly from the study's public registry record.

Talk to the study team

Dr. Sanaz Pournajaf, DPT  ·  +39 0652252405  ·  sanaz.pournajaf@sanraffaele.it

Dr. Raimondo Torcisi, PT  ·  raimondo.torcisi@sanraffaele.it

Always discuss trial participation with your own doctor first.

Locations (2)

San Raffaele CassinoCassino, Frosinone, ItalyNot Yet Recruiting
IRCCS San Raffaele RomaRome, Italy, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05773885